HSPA9 and cancer: In the near future, mtHsp70 will likely emerge as a therapeutic target for optic neuritis, Parkinson's and Alzheimer's diseases, and cancers [51], whereas human Hsp70-1 and Hsp70-2 also display different functions in different cancer cells.